Sequential usage of imidazole followed by tamoxifen to enhance the anticancer effect of tamoxifen in estrogen receptor-positive breast cancer cell lines.

被引：2
|
作者：
Inci, Tarik
Kahraman, Erkan
Goker, Erdem
机构：
[1] Ege Univ Hosp, Izmir, Turkey
[2] Ege Univ, Ataturk Hlth Care Vocat Sch, Izmir, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e15057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15057
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Understanding Resistance to Tamoxifen in Hormone Receptor-Positive Breast Cancer
    Higgins, Michaela J.
    Stearns, Vered
    CLINICAL CHEMISTRY, 2009, 55 (08) : 1453 - 1455
  • [22] Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
    Gao, Pin
    Wang, Xiang
    Jin, Ying
    Hu, Wenquan
    Duan, Yajun
    Shi, Aiping
    Du, Ye
    Song, Dong
    Yang, Ming
    Li, Sijie
    Han, Bing
    Zhao, Gang
    Zhang, Hongquan
    Fan, Zhimin
    Miao, Qing Robert
    BREAST CANCER RESEARCH, 2018, 20
  • [23] Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
    Pin Gao
    Xiang Wang
    Ying Jin
    Wenquan Hu
    Yajun Duan
    Aiping Shi
    Ye Du
    Dong Song
    Ming Yang
    Sijie Li
    Bing Han
    Gang Zhao
    Hongquan Zhang
    Zhimin Fan
    Qing Robert Miao
    Breast Cancer Research, 20
  • [24] Loss of B-cell translocation gene 2 in estrogen receptor-positive breast cancer and tamoxifen resistance
    Hayashida, T.
    Jinno, H.
    Takahashi, M.
    Kitagawa, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [25] MRP as a new predictive marker of tamoxifen efficiency in treatment of estrogen receptor-positive breast cancer
    T. A. Bogush
    E. A. Dudko
    E. A. Bogush
    M. V. Tikhomirov
    V. Yu. Kirsanov
    M. I. Davydov
    Doklady Biochemistry and Biophysics, 2010, 430 : 36 - 40
  • [26] Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics
    Slanar, Ondrej
    Hronova, Karolina
    Bartosova, Olga
    Sima, Martin
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (03) : 307 - 321
  • [27] Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
    Sherene Loi
    Benjamin Haibe-Kains
    Christine Desmedt
    Pratyaksha Wirapati
    Françoise Lallemand
    Andrew M Tutt
    Cheryl Gillet
    Paul Ellis
    Kenneth Ryder
    James F Reid
    Maria G Daidone
    Marco A Pierotti
    Els MJJ Berns
    Maurice PHM Jansen
    John A Foekens
    Mauro Delorenzi
    Gianluca Bontempi
    Martine J Piccart
    Christos Sotiriou
    BMC Genomics, 9
  • [28] Role of AIB1 for Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells
    Su, Qingbo
    Hu, Sanyuan
    Gao, Haidong
    Ma, Rong
    Yang, Qifeng
    Pan, Zhenhua
    Wang, Tiantian
    Li, Feng
    ONCOLOGY, 2008, 75 (3-4) : 159 - 168
  • [29] MRP as a new predictive marker of tamoxifen efficiency in treatment of estrogen receptor-positive breast cancer
    Bogush, T. A.
    Dudko, E. A.
    Bogush, E. A.
    Tikhomirov, M. V.
    Kirsanov, V. Yu.
    Davydov, M. I.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2010, 430 (01) : 36 - 40
  • [30] Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
    Loi, Sherene
    Haibe-Kains, Benjamin
    Desmedt, Christine
    Wirapati, Pratyaksha
    Lallemand, Francoise
    Tutt, Andrew M.
    Gillet, Cheryl
    Ellis, Paul
    Ryder, Kenneth
    Reid, James F.
    Daidone, Maria G.
    Pierotti, Marco A.
    Berns, Els Mjj
    Jansen, Maurice P. H. M.
    Foekens, John A.
    Delorenzi, Mauro
    Bontempi, Gianluca
    Piccart, Martine J.
    Sotiriou, Christos
    BMC GENOMICS, 2008, 9 (1)
12345